New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 6, 2012
19:02 EDTABMDAbiomed's Impella retains Class III status by the FDA
Abiomed announced that the FDA Circulatory System Devices Panel voted to retain Class III status for the temporary ventricular support devices within the non-roller type cardiopulmonary bypass blood pumps category, which includes Impella. The 515i Reclassification Panel's confirmation of this category of device as Class III devices is consistent with both the current Class III classification for these device types and as recommended in the FDA's briefing documents, released on December 3.
News For ABMD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 4, 2016
07:07 EDTABMDAbiomed sees Q4 revenue $90M, consensus $85.11M
Subscribe for More Information
07:07 EDTABMDAbiomed raises FY16 revenue outlook to $326M from $305M-$315M
Subscribe for More Information
07:06 EDTABMDAbiomed reports Q3 EPS 23c, consensus 15c
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use